Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $16.00

Aveanna Healthcare (NASDAQ:AVAH) had its price objective lifted by research analysts at Royal Bank Of Canada from $10.00 to $16.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank Of Canada’s price target points to a potential upside of 21.58% from the company’s current price.

A number of other research analysts have also issued reports on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Aveanna Healthcare in a research report on Thursday, July 2nd. UBS Group raised their price target on Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. Barclays lifted their price objective on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company an “overweight” rating in a research note on Thursday, July 9th. Truist Financial upped their price objective on shares of Aveanna Healthcare from $9.00 to $11.00 and gave the stock a “hold” rating in a report on Tuesday, July 14th. Finally, Raymond James Financial increased their target price on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a research report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $12.44.

Aveanna Healthcare Stock Performance

AVAH opened at $13.16 on Monday. The business’s 50 day moving average is $9.58 and its 200-day moving average is $7.92. The stock has a market cap of $2.87 billion, a PE ratio of 10.70, a price-to-earnings-growth ratio of 0.92 and a beta of 1.90. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. Aveanna Healthcare has a twelve month low of $5.93 and a twelve month high of $13.61.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The business had revenue of $670.48 million during the quarter, compared to the consensus estimate of $638.61 million. On average, analysts predict that Aveanna Healthcare will post 0.68 earnings per share for the current year.

Insider Activity

In related news, major shareholder Robert M. Williams, Jr. sold 7,000,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total value of $43,680,000.00. Following the sale, the insider directly owned 252,899 shares in the company, valued at $1,578,089.76. The trade was a 96.51% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Paul R. Vigano sold 7,000,000 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider directly owned 252,899 shares of the company’s stock, valued at approximately $1,578,089.76. This represents a 96.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 31,180,664 shares of company stock worth $214,607,160. Corporate insiders own 5.30% of the company’s stock.

Institutional Trading of Aveanna Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. California State Teachers Retirement System raised its holdings in shares of Aveanna Healthcare by 1,351.3% during the second quarter. California State Teachers Retirement System now owns 730,027 shares of the company’s stock valued at $6,256,000 after acquiring an additional 679,727 shares during the period. Braidwell LP grew its position in Aveanna Healthcare by 39.1% during the 2nd quarter. Braidwell LP now owns 3,065,106 shares of the company’s stock worth $26,268,000 after purchasing an additional 861,600 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Aveanna Healthcare by 17.6% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 96,956 shares of the company’s stock valued at $831,000 after purchasing an additional 14,492 shares during the period. Littlejohn & Co. LLC purchased a new stake in shares of Aveanna Healthcare in the second quarter valued at $1,846,878,000. Finally, Corient Private Wealth LP purchased a new stake in shares of Aveanna Healthcare in the second quarter valued at $176,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.